深圳欣生源生物科技有限公司再次簽約美國Sea Run Holdings公司中國區(qū)獨(dú)代授權(quán)商(Sole Agency Agreement)。我司已同美國Sea Run Holdings公司簽約合作多年，共同合作研究開發(fā)再生醫(yī)學(xué)研究試劑，力爭為廣大的科研工作者提供更好，更專業(yè)的服務(wù)。

Salmon fibrinogen (SEA-133) and fibrin ECM 鮭魚蛋白原

• Excellent proliferation of stem cells and retention of “stemness” (Zhou et al. Stem Cell Trans. Medicine. 2017;6(5):1412-1423)
• Superior to Matrigel for neurite outgrowth and neuronal cell growth (Ju et al. Biomaterials. 2007 April; 28 (12): 2097-2108)
• More efficient ECM (60-188%) than human derived fibrin gels for angiogenesis. (Sieminski et al.  2004. J Biomater Sci Polym. Ed 15(2):237-42)
• Slower gel degradation in vitro and in vivo
• Selection and growth of tumorigenic cells (Liu J et al. Nat. Mater. 2012 Jul 1, 11(8):734-41)

Salmon thrombin (SEA-135)  鮭魚凝血酶

• Optimal polymerization of salmon fibrinogen
• Significant and sustained analgesia for pain studies (Weisshaar et al. 2011 Biomaterials:9738-9746)
• Potential alternative for opioids.
• Blocks disruption of blood-brain barrier. (Smith et al. 2016. BioMaterials 80: 96-105).